iSpecimen Inc. SEC filings ISPC
iSpecimen Inc. has 333 filings in SEC EDGAR's recent list, going back to Sep 25, 2012. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, acquisition or sale of assets, unregistered share sale, change in control, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Aug 7, 2026 | — |
| S-1/A | Amended registration statement | Jul 17, 2026 | — |
| S-1/A | Amended registration statement | Jul 6, 2026 | — |
| S-1 | Registration statement | Jun 24, 2026 | — |
| S-3 | Shelf registration | Jun 4, 2026 | — |
| 424B3 | Prospectus | Feb 3, 2026 | — |
| S-3 | Shelf registration | Jan 20, 2026 | — |
| 424B3 | Prospectus | Jan 2, 2026 | — |
| S-1/A | Amended registration statement | Dec 19, 2025 | — |
| S-3 | Shelf registration | Oct 23, 2025 | — |
| S-1/A | Amended registration statement | Oct 6, 2025 | — |
| S-1/A | Amended registration statement | Sep 8, 2025 | — |
| S-1/A | Amended registration statement | Aug 25, 2025 | — |
| S-1 | Registration statement | Aug 20, 2025 | — |
| 424B4 | Prospectus | Jul 25, 2025 | — |
| S-1/A | Amended registration statement | Jul 8, 2025 | — |
| S-1/A | Amended registration statement | Jun 27, 2025 | — |
| S-1/A | Amended registration statement | Jun 11, 2025 | — |
| S-1/A | Amended registration statement | May 23, 2025 | — |
| S-1 | Registration statement | May 2, 2025 | — |
| 424B4 | Prospectus | Oct 31, 2024 | — |
| S-1 | Registration statement | Oct 18, 2024 | — |
| 424B5 | Prospectus supplement | Mar 5, 2024 | — |
| 424B3 | Prospectus | Dec 30, 2022 | — |
| 424B3 | Prospectus | Aug 5, 2022 | — |
| S-3 | Shelf registration | Jul 29, 2022 | — |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| 424B3 | Prospectus | Jun 7, 2022 | — |
| POS AM | Form pos am | May 26, 2022 | — |
| 424B3 | Prospectus | Dec 23, 2021 | — |
| S-8 | Employee stock plan registration | Dec 16, 2021 | — |
| S-1 | Registration statement | Dec 14, 2021 | — |
| 424B4 | Prospectus | Jun 21, 2021 | — |
| FWP | Free writing prospectus | May 28, 2021 | — |
| S-1/A | Amended registration statement | May 27, 2021 | — |
| S-1/A | Amended registration statement | May 13, 2021 | — |
| S-1/A | Amended registration statement | Apr 27, 2021 | — |
| S-1/A | Amended registration statement | Apr 2, 2021 | — |
| S-1/A | Amended registration statement | Jan 20, 2021 | — |
| S-1/A | Amended registration statement | Dec 31, 2020 | — |
| S-1 | Registration statement | Nov 19, 2020 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ISPC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woburn, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1558569
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.